天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Shanghai Aladdin Biochemical Technology Co.,Ltd.??? ?? ??? ?????.

?? ?:Shanghai Aladdin Biochemical Technology Co.,Ltd.
??:400-6206333
???:market@aladdin-e.com
??:China
URL: www.aladdin-e.com/
? ?? ?:48461
460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485

?? ????

Muromonab (anti-CD3)140608-64-6
Mupadolimab (anti-CD73)2451856-97-4
Amatuximab (anti-MSLN)931402-35-6
Aducanumab (anti-APP)?????1384260-65-4
Aprutumab (anti-FGFR2)1634620-63-5
Anifrolumab (anti-IFNAR1)1326232-46-5
Rovalpituzumab (anti-DLL3)1613313-01-1
Simtuzumab (anti-LOXL2)1318075-13-6
Sifalimumab (anti-IFNa1)1006877-41-3
Onvatilimab (anti-VISTA)1969313-51-6
Ibalizumab (anti-CD4)680188-33-4
Figitumumab (anti-IGF1R)943453-46-1
Onartuzumab (anti-MET)1133766-06-9
Belantamab (anti-TNFRSF17)2061894-48-0
Erenumab (anti-CALCRL)1582205-90-0
Omburtamab (anti-CD276)1895083-75-6
Envafolimab (anti-PD-L1)2102192-68-5
Margetuximab (anti-HER2)1350624-75-7
Varlilumab (anti-TNFRSF7)1393344-72-3
Fletikumab (anti-IL-20)1357158-22-5
Nadunolimab (anti-IL-1 RAcP)2171061-85-9
Penpulimab (anti-PDCD1)2350298-92-7
Fezakinumab (anti-IL-22)1007106-86-6
Otelixizumab (anti-CD3)881191-44-2
Sotigalimab (anti-CD40)2305607-45-6
Zilovertamab (anti-ROR1)2485779-13-1
Farletuzumab (anti-FOLR1)896723-44-7
Selicrelumab (anti-CD40)1622140-49-1
Teprotumumab (anti-IGF1R)1036734-93-6
Blosozumab (anti-SOST)1132758-87-2
Olokizumab (anti-IL-6)1007223-17-7
Canakinumab (Anti-IL-1b)914613-48-2
Etrolizumab (anti-α4β7)1044758-60-2
Mavrilimumab (anti-CD116)1085337-57-0
Sofituzumab (anti-MUC16)1615692-28-8
Tregalizumab (anti-CD4)1207446-68-1
Teplizumab (anti-CD3e)876387-05-2
Bemarituzumab (anti-FGFR2)1952272-74-0
Eptinezumab (anti-CGRP)1644539-04-7
Emicizumab (anti-Factor IX)1610943-06-0
Patritumab (anti-ERBB3)1262787-83-6
Motavizumab (anti-RSV-F)?????677010-34-3
Mirvetuximab (anti-FOLR1)1453084-36-0
Abituzumab (anti-ITGAV)1105038-73-0
Zinc selenide???? ??(??? ??)1315-09-9SeZn
Z-FA-FMK197855-65-5C21H23FN2O4
Zirconium acetate????, ???? ?7585-20-8C2H4O2Zr
Zearalenone from Giberella zeae????17924-92-4C18H22O5
Zanamivir139110-80-8C12H20N4O7
Zinc acetylacetonate hydrate108503-47-5C10H14O4Zn
Etokimab (anti-IL-33)2022981-44-6
Tremelimumab (anti-CTLA-4)?????????????745013-59-6
Denosumab (anti-TNFSF11)????(??)615258-40-7C6404H9912N1724O2004S50
Sintilimab (anti-PD-1)2072873-06-2
Zinc iron oxide12063-19-3Fe2O4Zn
Panitumumab (anti-EGFR)?????339177-26-3
Mepolizumab (anti-IL-5)?????196078-29-2
Sacituzumab (anti-TROP2)1796566-95-4
Magrolimab (anti-CD47)2169232-81-7
Vibostolimab (anti-TIGIT)2231305-30-7
Relatlimab (anti-LAG-3/CD223)1673516-98-7
Ofatumumab (anti-CD20)?????679818-59-8
Zandelisib1401436-95-0C31H38F2N8O
Zoledronic Acid118072-93-8C5H10N2O7P2
Spartalizumab (anti-PD-1)1935694-88-4
Risankizumab (anti-IL-23)1612838-76-2
Omalizumab (anti-IgE)?????242138-07-4
ZM 39923 HCl1021868-92-7C23H26ClNO
Zibotentan (ZD4054)186497-07-4C19H16N6O4S
Recombinant Human VEGF Protein????? ???????????-40?????-??????-9127464-60-2NULL
Vedolizumab (anti-α4β7-integrin)943609-66-3
Zalcitabine????7481-89-2C9H13N3O3
Tiragolumab (anti-TIGIT)1918185-84-8
Brodalumab (anti-IL17RA)1174395-19-7
Zebularine (NSC 309132)3690-10-6C9H12N2O5
Isatuximab (anti-CD38)1461640-62-9
Zafirlukast (ICI-204219)107753-78-6C31H33N3O6S
Evolocumab(anti-PCSK9)?????1256937-27-5
Pamrevlumab (anti-CTGF)946415-13-0
Emapalumab (anti-IFNγ)1709815-23-5
Z-LEHD-FMK TFA524746-03-0C34H44F4N6O12
Zolantidine dimaleate104076-39-3C22H27N3OS2C4H4O4
Zoledronic Acid Disodium Salt Tetrahydrate???????????????165800-07-7C5H13N2NaO8P2
Siltuximab (anti-IL-6)541502-14-1
Necitumumab (anti-EGFR)906805-06-9
Zolmitriptan139264-17-8C16H21N3O2
Zileuton (A-64077)111406-87-2C11H12N2O2S
Zaltoprofen74711-43-6C17H14O3S
Zinc Pyrithione?? ????13463-41-7C10H8N2O2S2Zn
Zinc fluoborate hydrate27860-83-9BF4H2OZn+
Zirconium hydroxide???? ????14475-63-9H4O4Zr
ZM 306416690206-97-4C16H13ClFN3O2
Evinacumab (anti-ANGPTL3)1446419-85-7
Sabatolimab (anti-TIM-3)2252262-24-9
Brentuximab (anti-TNFRSF8)2088770-90-3
Cusatuzumab (anti-CD70)1864871-20-4
Naxitamab (anti-GD2)1879925-92-4
Talquetamab (anti-GPRC5D)2226212-40-2
Oleclumab (anti-CD73)1803176-05-7
Lorvotuzumab (anti-CD56)339306-30-8
460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485
Copyright 2019 ? ChemicalBook. All rights reserved